Table 3.
Clinical follow-up parameters
| Patient 1 | Patient 2 | Patient 3 | ||||
|---|---|---|---|---|---|---|
| 3 months | 6 months | 3 months | 6 months | 3 months | 6 months | |
| Drop in mean office blood pressure (mm Hg) | −31/+2 | −62/−18 | +8/−5 | +28/+10 | −50/−23 | −30/−10 |
| Drop in ambulatory blood pressure (mm Hg) | −44/−28 | −16/−22 | −2/+3 | −9/−4 | −2/−4 | −20/−12 |
| Change in heart rate (bpm) | 0 | 0 | −8 | −2 | −19 | −9 |
| Change in eGFR (ml/min) | 0 | +5 | +6 | −5 | 0 | 0 |
| Antihypertensive medication | ||||||
| Ace inhibitor | Yes | Yes | No | No | No | No |
| Angiotensin receptor blocker | No | No | Yes | Yes | Yes | Yes |
| Diuretic | Yes, dose decreased | Yes | Yes | Yes, dose increased | No | No |
| Calcium channel blocker | Intolerant | Intolerant | Yes | Yes | No | No |
| Alpha blocker | No | No | Yes | Yes | No | No |
| Beta blocker | Yes | Yes | Yes | Yes | Yes | Yes |
| Aldosterone receptor antagonist | No | Yes | No | No | No | No |
| Vasodilator | No | No | No | No | No | No |
| Adverse events | ||||||
| Death | No | No | No | No | No | No |
| Myocardial infarction | No | No | No | No | No | No |
| Stroke/TIA | No | No | No | No | No | No |